A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this randomized, double-blind, placebo-controlled study is to assess the safety and efficacy of PRX-00023 in patients with major depressive disorder.
Epistemonikos ID: f7332a7befcd45a33d0a13ee1f54e0a648566dc0
First added on: May 04, 2024